PMC3350270_01
Protocol of standard bridging therapy and medications in patients with low thromboembolism risk/high bleeding risk. LMWH is continued until the INR has returned to the therapeutic level. LMWH: low molecular weight heparin; OP: operation; POP: postoperatively; INR: international normalized ratio.
CRIM.ANESTHESIOLOGY2011-359867.001.jpg
PMC3350270_01_CRIM.ANESTHESIOLOGY2011-359867.001.jpg
fig1
The postoperative bridging therapy regimen proposed by the cardiologist was 60 mg enoxaparin, a LMWH, administered subcutaneously twice daily and was continued until the INR returned to therapeutic levels (Figure 1). As shown in Figure 1, bridging therapy with enoxaparin 0.75 mg/kg was subcutaneously administered 4 hrs postoperatively and then twice daily for the next 2 days.
Delayed right neck hematoma. (a) Gross appearance of the neck after surgery. (b) Ultrasound image of right neck showed edematous muscles and swelling connective tissues. No thrombus in the jugular vein: common carotid artery (A), internal jugular vein (V), and edematous muscle layers (M).
CRIM.ANESTHESIOLOGY2011-359867.002.jpg
PMC3350270_01_CRIM.ANESTHESIOLOGY2011-359867.002.jpg
fig2
Ultrasound examination of the swollen area of the right neck showed diffuse hematoma (Figure 2(a)). After operation, a drainage tube was placed over the right neck (Figure 2(b)).